{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T02:09:59Z","timestamp":1792375799743,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.nmd.2010.01.005","type":"journal-article","created":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T04:48:41Z","timestamp":1265086121000},"page":"192-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Microvasculopathic neuromuscular diseases: Lessons from hypoxia-inducible factors"],"prefix":"10.1016","volume":"20","author":[{"given":"Stefan","family":"Probst-Cousin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Neund\u00f6rfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Heuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2010.01.005_bib1","series-title":"Structural and molecular basis of skeletal muscle diseases","first-page":"218","article-title":"Dysimmune myopathies. Definition of entities and experimental models of myositis","author":"Hohlfeld","year":"2002"},{"key":"10.1016\/j.nmd.2010.01.005_bib2","series-title":"Structural and molecular basis of skeletal muscle diseases","first-page":"221","article-title":"Polymyositis and dermatomyositis","author":"Hohlfeld","year":"2002"},{"key":"10.1016\/j.nmd.2010.01.005_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1445-5994.2008.01822.x","article-title":"Idiopathic inflammatory myopathies","volume":"39","author":"Limaye","year":"2009","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.nmd.2010.01.005_bib4","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/WNL.55.5.636","article-title":"Superficial peroneal nerve\/peroneus brevis muscle biopsy in vasculitic neuropathy","volume":"55","author":"Collins","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2010.01.005_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1600-0404.1993.tb05515.x","article-title":"Immunohistochemical findings in vasculitic neuropathies","volume":"87","author":"Engelhard","year":"1993","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nmd.2010.01.005_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.410250314","article-title":"Peripheral nerve vasculitis: immune characterization of the vascular lesions","volume":"25","author":"Kissel","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nmd.2010.01.005_bib7","first-page":"1","article-title":"The vasculitides","volume":"21","author":"Cupps","year":"1981","journal-title":"Major Probl. Intern. Med."},{"key":"10.1016\/j.nmd.2010.01.005_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.nmd.2010.01.005_bib9","unstructured":"Carpenter S, Karpati G. Inflammatory myopathies. In: Carpenter S, Karpati G editors. Pathology of skeletal muscle. 2nd ed., Oxford: Oxford University Press; 2001. p. 542\u2013543."},{"key":"10.1016\/j.nmd.2010.01.005_bib10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/archneurpsyc.1938.02270040011001","article-title":"Periarteritis nodosa. A clinicopathologic study with special reference to the nervous system","volume":"39","author":"Kernohan","year":"1938","journal-title":"Arch. Neurol. Psych."},{"key":"10.1016\/j.nmd.2010.01.005_bib11","series-title":"Biopsy diagnosis of peripheral neuropathy","first-page":"241","article-title":"Vasculitic neuropathy","author":"Midroni","year":"1995"},{"key":"10.1016\/j.nmd.2010.01.005_bib12","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/1097-4598(200007)23:7<999::AID-MUS1>3.0.CO;2-I","article-title":"Cell death in vasculitic neuropathy","volume":"23","author":"Heuss","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2010.01.005_bib13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1212\/WNL.50.2.492","article-title":"Mechanisms of tissue injury in vasculitic neuropathies","volume":"50","author":"Satoi","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2010.01.005_bib14","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nmd.2010.01.005_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00424-001-0759-8","article-title":"Oxygen sensing, HIF-1\u03b1 stabilization and potential therapeutic strategies","volume":"443","author":"Hofer","year":"2002","journal-title":"Pfl\u00fcgers Arch. Eur. J. Physiol."},{"key":"10.1016\/j.nmd.2010.01.005_bib16","first-page":"214","article-title":"HIF-1, a mediator of the molecular response to hypoxia","volume":"12","author":"Gassmann","year":"1997","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.nmd.2010.01.005_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/01.CIR.100.5.468","article-title":"Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease","volume":"100","author":"Rosengart","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.nmd.2010.01.005_bib18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1046\/j.1365-2133.1998.02563.x","article-title":"Serum concentrations of vascular endothelial growth factor in collagen diseases","volume":"139","author":"Kikuchi","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.nmd.2010.01.005_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2010.01.005_bib20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00019052-200410000-00006","article-title":"Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis","volume":"17","author":"Dalakas","year":"2004","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nmd.2010.01.005_bib21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1056\/NEJM200003023420904","article-title":"Early expression of angiogenesis factors in acute myocardial ischemia and infarction","volume":"342","author":"Lee","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nmd.2010.01.005_bib22","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9440(10)62566-7","article-title":"Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR\/Flk-1) in ischemic skeletal muscle and its regeneration","volume":"160","author":"Rissanen","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nmd.2010.01.005_bib23","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1096\/fj.01-0125com","article-title":"HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia","volume":"15","author":"Stroka","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.nmd.2010.01.005_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1440-1789.2007.00817.x","article-title":"Hypoxia-inducible factor 1\u03b1 may be a marker for vasculitic neuropathy","volume":"27","author":"Oka","year":"2009","journal-title":"Neuropathology"},{"key":"10.1016\/j.nmd.2010.01.005_bib25","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1073\/pnas.90.9.4304","article-title":"General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia","volume":"90","author":"Wang","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nmd.2010.01.005_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00296-003-0379-z","article-title":"Disease-associated increased HIF-1, av\u03b23 integrin, and Flt-1 do not suffice to compensate the damage-inducing loss of blood vessels in inflammatory myopathies","volume":"24","author":"Konttinen","year":"2004","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.nmd.2010.01.005_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.11.1.72","article-title":"Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells","volume":"11","author":"Tian","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.nmd.2010.01.005_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1096\/fj.02-0445fje","article-title":"Widespread, hypoxia-inducible expression of HIF-2\u03b1 in distinct cell populations of different organs","volume":"17","author":"Wiesener","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.nmd.2010.01.005_bib29","doi-asserted-by":"crossref","first-page":"C1487","DOI":"10.1152\/ajpcell.2001.281.5.C1487","article-title":"Functional and molecular adaptations in skeletal muscle of myoglobin-mutant mice","volume":"281","author":"Grange","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.nmd.2010.01.005_bib30","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood.V93.12.4284","article-title":"Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter\/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice","volume":"93","author":"Kappel","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.nmd.2010.01.005_bib31","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1074\/jbc.274.4.2060","article-title":"Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia-inducible factor 1\u03b1","volume":"274","author":"O\u2019Rourke","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nmd.2010.01.005_bib32","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1073\/pnas.94.9.4273","article-title":"A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1\u03b1 regulates the VEGF expression and is potentially involved in lung and vascular development","volume":"94","author":"Ema","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nmd.2010.01.005_bib33","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nmd.2010.01.005_bib34","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1074\/jbc.271.7.3877","article-title":"The mouse gene for vascular endothelial growth factor: genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences","volume":"271","author":"Shima","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nmd.2010.01.005_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.nmd.2010.01.005_bib36","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/01.RES.86.12.1198","article-title":"Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects","volume":"86","author":"Kalka","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.nmd.2010.01.005_bib37","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.23884","article-title":"Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis","volume":"58","author":"Grundtman","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.nmd.2010.01.005_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/153537020322800101","article-title":"Erythropoietin: physiology and pharmacology update","volume":"228","author":"Fisher","year":"2003","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.nmd.2010.01.005_bib39","first-page":"215","article-title":"Expression of erythropoietin in human female reproductive organs","volume":"106","author":"Yasuda","year":"2001","journal-title":"Ital. J. Anat. Embryol."},{"key":"10.1016\/j.nmd.2010.01.005_bib40","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1073\/pnas.152321399","article-title":"Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury","volume":"99","author":"Junk","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nmd.2010.01.005_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1651-2227.2002.tb02904.x","article-title":"Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage","volume":"91","author":"Juul","year":"2002","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.nmd.2010.01.005_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00347-003-0785-3","article-title":"Angiogenesis research \u2013 Quo vadis? (in German)","volume":"100","author":"Augustin","year":"2003","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.nmd.2010.01.005_bib43","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1006\/exnr.2001.7808","article-title":"Do denervated peripheral nerve trunks become ischemic? The impact of chronic denervation on vasa nervorum","volume":"172","author":"Hoke","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nmd.2010.01.005_bib44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/74664","article-title":"Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy","volume":"6","author":"Schratzberger","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.nmd.2010.01.005_bib45","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1152\/ajpheart.2000.279.3.H932","article-title":"Fiber type-specific differential expression of angiogenic factors in response to chronic hindlimb ischemia","volume":"279","author":"Cherwek","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.nmd.2010.01.005_bib46","first-page":"752","article-title":"Increased expression of vascular endothelial growth factor in human skeletal muscle in response to short-term one-legged exercise training","volume":"444","author":"Gustafsson","year":"2003","journal-title":"Pfl\u00fcgers Arch."},{"key":"10.1016\/j.nmd.2010.01.005_bib47","doi-asserted-by":"crossref","first-page":"H679","DOI":"10.1152\/ajpheart.1999.276.2.H679","article-title":"Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle","volume":"45","author":"Gustafsson","year":"1999","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.nmd.2010.01.005_bib48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4757-3401-0_4","article-title":"Skeletal muscle angiogenesis. A possible role for hypoxia","volume":"502","author":"Wagner","year":"2001","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nmd.2010.01.005_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-3-2","article-title":"Endothelial cell activation and neovascularization are prominent in dermatomyositis","volume":"3","author":"Nagaraju","year":"2006","journal-title":"J. Autoimmune Dis."},{"key":"10.1016\/j.nmd.2010.01.005_bib50","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10875-007-9083-1","article-title":"Vascular endothelial growth factor (VEGF) in autoimmune diseases","volume":"27","author":"Carvalho","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.nmd.2010.01.005_bib51","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1097-2765(00)80154-9","article-title":"VEGF gene delivery to muscle: potential role for vasculogenesis in adults","volume":"2","author":"Springer","year":"1998","journal-title":"Mol. Cell."},{"key":"10.1016\/j.nmd.2010.01.005_bib52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.gt.3301969","article-title":"Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia","volume":"10","author":"Khan","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.nmd.2010.01.005_bib53","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000291619.17160.b8","article-title":"Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications","volume":"69","author":"Greenberg","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2010.01.005_bib54","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1212\/01.wnl.0000279589.06059.37","article-title":"Revisiting the immunopathogenesis of the inflammatory myopathies","volume":"69","author":"Hohlfeld","year":"2007","journal-title":"Neurology"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896610000180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896610000180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:57:54Z","timestamp":1760774274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896610000180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0960896610000180"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2010.01.005","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microvasculopathic neuromuscular diseases: Lessons from hypoxia-inducible factors","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2010.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}